Tu1767 HIGHER PREDICTIVE POWER OF EPIGENETIC SIGNATURES FOR RESPONSE TO VEDOLIZUMAB AND USTEKINUMAB IN ANTI-TNF NAÏVE PATIENTS WITH ACTIVE CROHN'S DISEASE
Gastroenterology(2024)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined